Risk mitigation in bioanalysis to maintain the integrity of drug development studies

In this video, Mercodia presents a webinar featuring Tanja Jarhede, Senior Scientist, who discusses common challenges faced in developing ligand binding assays (LBA). LBAs are crucial for quantifying biopharmaceuticals and biomarkers, as well as assessing immunogenicity in preclinical and clinical studies. The presentation emphasizes key considerations for building a robust assay with high specificity and selectivity, drawing from Mercodia's extensive experience in the field.